Table 1 Clinical and pathological features of LC, PCa and CRC patient and ACs included in this study

Number

136

323

Age median (range)

57 (48–66)

68 (27–93)

 Number

102

 Age median (range)

66 (45–89)

 Histological type

n.a.

  Non-small cell lung carcinoma (NSCLC)

   Adenocarcinoma

42

   Squamous cell carcinoma

43

   Large cell carcinoma

1

  Small cell lung carcinoma (SCLC)

16

 Primary tumour (T)^a

n.a.

  T1

12

  T2/T3/T4

82

 Regional lymph node (N)^b

n.a.

  N0

25

  N+

72

 Distant metastasis (M)

n.a.

  M0

47

  M+

55

 Clinical stage

n.a.

  I/II

17

  III/IV

85

 Number

121

 Age median (range)

71 (52–88)

 Histological type

n.a.

  Adenocarcinoma

121

 Primary tumour (T)^c

n.a.

  T1/T2

104

  T3

16

 Regional lymph node (N)

n.a.

  N0

119

  N+

2

 Distant metastasis (M)

n.a.

  M0

116

  M+

5

 Grade group

n.a.

  1

59

  2

38

  3/4/5

24

 Serum PSA levels (ng/mL)

n.a.

  < 10

71

  10–20

27

  > 20

23

 Clinical stage

n.a.

  I

31

  II

55

  III/IV

35

 Number

100

 Age median (range)

66 (27–93)

 Histological Type

n.a.

  Adenocarcinoma (all subtypes)

99

  Squamous cell carcinoma

1

 Tumour location

n.a.

  Proximal colon

23

  Distal colon

36

  Rectum

41

 Primary tumour (T)^d

n.a.

  T1/T2

26

  T3/T4

72

 Regional lymph node (N)^e

n.a.

  N0

40

  N+

57

 Distant metastasis (M)

n.a.

  M0

82

  M+

18

 Clinical stage

n.a.

  I/II

39

  III/IV

61